Cingulate Inc. (CING)
- Previous Close
4.3400 - Open
4.3300 - Bid --
- Ask --
- Day's Range
4.3300 - 4.4600 - 52 Week Range
1.8000 - 152.4000 - Volume
20,626 - Avg. Volume
3,896,915 - Market Cap (intraday)
13.333M - Beta (5Y Monthly) -0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-326.4000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
80.33
Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
www.cingulate.comRecent News: CING
View More
Performance Overview: CING
Trailing total returns as of 10/29/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CING
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CING
View MoreValuation Measures
Market Cap
13.21M
Enterprise Value
13.16M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.28
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-225.76%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-19.1M
Diluted EPS (ttm)
-326.4000
Balance Sheet and Cash Flow
Total Cash (mrq)
380.93k
Total Debt/Equity (mrq)
10.72%
Levered Free Cash Flow (ttm)
-12.05M
Research Analysis: CING
View MoreCompany Insights: CING
CING does not have Company Insights
Research Reports: CING
View MoreDaily – Vickers Top Insider Picks for 02/22/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/21/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/17/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/16/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.